Literature DB >> 6138609

Diagnostic effectiveness of ultrasound in detection of neural tube defect. The South Wales experience of 2509 scans (1977-1982) in high-risk mothers.

C J Roberts, K T Evans, B M Hibbard, K M Laurence, E E Roberts, I B Robertson.   

Abstract

2509 pregnant women were investigated between April 1, 1977, and March 31, 1980 (study 1), and April 1, 1980, and March 31, 1983 (study 2), to assess the effectiveness of diagnostic ultrasound in the diagnosis of neural tube defect (NTD) in women judged to be at high risk of NTD on the basis of raised serum alpha-fetoprotein or family history, or of other congenital malformation. The detection rate (sensitivity) for anencephaly was 100% in both studies. The detection rate for open spina bifida (OSB) improved from 33% in study 1 to 80% in study 2, specificity rose from 96% to 99%, the false-positive rate dropped from 57% to 9%, and the false-negative rate fell from 1% to 0.3%. Diagnostic ultrasound is likely to be conducted with greater vigilance and subjected to greater scrutiny than routine ultrasound because the patients have already been selected as being at high risk, the operators are more experienced, and their apparatus is likely to be more refined than that used for routine ultrasound. It is unlikely that the effectiveness levels for detection of OSB of 80% observed in this study could be sustained if diagnostic ultrasound were to be offered to all pregnant women. Consideration will need to be given to the question of whether an improved OSB detection rate will be worth the additional cost incurred in providing diagnostic ultrasound for every pregnant woman.

Entities:  

Mesh:

Year:  1983        PMID: 6138609     DOI: 10.1016/s0140-6736(83)91049-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  6 in total

1.  Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a combined study in Germany and short overview on screening in populations with low birth prevalence of neural tube defects.

Authors:  W Fuhrmann; H K Weitzel
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

2.  Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project.

Authors:  T A Doran; G H Valentine; P Y Wong; G Wielgosz; R J Benzie; H C Soltan; M R Jenner; P A Morland; R J Montgomery; L C Allen
Journal:  CMAJ       Date:  1987-08-15       Impact factor: 8.262

3.  Prevalence and prenatal diagnosis of neural tube defects in Nova Scotia in 1980-84.

Authors:  E J Winsor; B S Brown
Journal:  CMAJ       Date:  1986-12-01       Impact factor: 8.262

4.  Which prescriptive screening programmes are worth while?

Authors:  J M Chamberlain
Journal:  J Epidemiol Community Health       Date:  1984-12       Impact factor: 3.710

5.  Should women at high risk of neural tube defect have an amniocentesis?

Authors:  K M Laurence; G Elder; K T Evans; B M Hibbard; M Hoole; C J Roberts
Journal:  J Med Genet       Date:  1985-12       Impact factor: 6.318

6.  Can we afford screening for neural tube defects? The South Wales experience.

Authors:  B M Hibbard; C J Roberts; G H Elder; K T Evans; K M Laurence
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.